Valuation: Cogstate Limited

Market Cap 626M 436M 392M 366M 331M 622M 41.47B 4.39B 1.71B 21.52B 1.64B 1.6B 69.22B P/E 2027 *
28.4x
P/E 2028 * 22.1x
Enterprise Value 561M 391M 351M 328M 297M 558M 37.19B 3.94B 1.54B 19.3B 1.47B 1.44B 62.08B EV / Sales 2027 *
5.18x
EV / Sales 2028 * 4.36x
Free-Float
56.43%
Yield 2027 *
1.37%
Yield 2028 * 1.67%
1 day-3.02%
1 week+3.52%
Current month+3.52%
1 month+12.42%
3 months+27.90%
6 months+47.70%
Current year+56.19%
1 week 3.24
Extreme 3.24
3.98
1 month 3.1
Extreme 3.1
3.98
Current year 2.01
Extreme 2.01
3.98
1 year 1.75
Extreme 1.75
3.98
3 years 0.8
Extreme 0.795
3.98
5 years 0.8
Extreme 0.795
3.98
10 years 0.16
Extreme 0.155
3.98
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 1999-12-16
Chief Executive Officer - 2005-11-30
Director of Finance/CFO - 2021-01-31
Director TitleAgeSince
Director/Board Member - 2011-02-28
Chairman 67 2009-11-02
Director/Board Member - 2017-01-19
Date Insider Type Main position Quantity % Market Cap. Importance
5/20/26 Buy

Director

3,600 0.0021%
5/20/26 Buy

Director

430 0.0003%
4/15/26
Myer & Myer Pty Ltd.
SellCompany 9,974,569 5.8334%
Change 5-day change 1-year change 3-year change Capi.($)
-3.02%+3.52%+44.08%+143.45% 436M
-2.01%-7.86%+60.74%+70.97% 68.92B
+0.62%+6.41%+7.01%+59.74% 51.9B
+2.87%+6.82%+12.11%+41.23% 48.73B
+0.51%+1.51%+27.96%+31.43% 43.13B
+2.70%-3.66%+307.41%+547.01% 41.48B
+0.69%-3.44%+9.52%+96.59% 39.96B
+0.06%-2.02%+11.25%+43.27% 30.6B
-2.21%-10.09%+35.34%-0.73% 26.01B
-0.39%-6.92%-13.60%-14.40% 22.27B
Average +0.07%-3.39%+50.18%+101.85% 37.34B
Weighted average by Cap. +0.40%-4.26%+54.78%+104.31%

Financials

2027 *2028 *
Net sales 108M 75.49M 67.87M 63.34M 57.41M 108M 7.18B 760M 297M 3.73B 283M 277M 11.99B 125M 86.82M 78.06M 72.85M 66.03M 124M 8.26B 874M 341M 4.29B 326M 319M 13.79B
Net income 22.07M 15.36M 13.81M 12.89M 11.68M 21.93M 1.46B 155M 60.4M 759M 57.67M 56.43M 2.44B 28.06M 19.53M 17.56M 16.39M 14.85M 27.88M 1.86B 197M 76.79M 965M 73.32M 71.73M 3.1B
Net Debt -64.61M -44.98M -40.44M -37.74M -34.2M -64.21M -4.28B -453M -177M -2.22B -169M -165M -7.14B -82.28M -57.27M -51.49M -48.05M -43.55M -81.77M -5.45B -577M -225M -2.83B -215M -210M -9.1B
Projected Income Statement - Annual - Cogstate Limited
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
26-10-15 A$3.530 -3.02% 704,749
26-10-14 A$3.640 -3.45% 445,260
26-10-13 A$3.770 -0.79% 1,041,057
26-10-12 A$3.800 +10.14% 1,011,050
26-10-09 A$3.450 +1.17% 165,049
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Cogstate Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.640AUD
Average target price
4.409AUD
Spread / Average Target
+21.13%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cogstate Limited